WEB Recursion RXRX to Host Learnings Call August 8th
RXRX to Provide Updates on Oncology and Rare Disease Clinical Programs
Call Scheduled for 5:00 PM ET / 3:00 PM MT
WEB Recursion Pharmaceuticals Inc. (RXRX) announced today that it will host a Learnings Call on August 8, 2024, at 5:00 PM Eastern Time (3:00 PM Mountain Time). The Company plans to provide updates on its oncology and rare disease clinical programs.
Recursion Pharmaceuticals is a TechBio company that decodes biology and chemistry to industrialize drug discovery. The Company's platform combines machine learning, biology, and chemistry to identify and develop new therapies for a wide range of diseases.
In recent news, Recursion Pharmaceuticals reported a net loss of $975.5 million for the second quarter of 2024. The Company attributed the loss to increased research and development spending. Recursion Pharmaceuticals also announced that it had begun dosing patients in a Phase 2 clinical trial of its lead oncology candidate, REC-485.
To participate in the Learnings Call, please register at the following link: [Registration Link]. A replay of the call will be available on the Company's website following the event.
Comments